Ectica Technologies is sponsoring the BACR Response and Resistance in Cancer Therapy conference
Updated: Jan 26
Ectica Technologies will sponsor and attend the British Association for Cancer Research (BACR) conference entitled Response and Resistance in Cancer Therapy taking place from the 6th to the 8th September 2021 (virtual). This meeting will bring together cancer researchers from academia and industry to focus on two research topics that are fundamental to ensuring that both established and novel treatments can be applied to bring maximum benefit for cancer patients: i) How can we predict in advance which patients will benefit from a given treatment? ii) How can we anticipate, monitor and prevent the evolution of drug resistance in cancer?
Exceptional invited speakers will cover the discovery of novel targets and resistance mechanisms in cancer cells, to analysis of the tumour microenvironment, the clinical development of immunotherapies and the use of liquid biopsies for disease monitoring.